Breaking News

Tweet TWEET

Highline Research Advisors initiates coverage on Trovagene (NASDAQ:TROV) with a buy rating.

Highline Research Advisors initiates coverage on Trovagene (NASDAQ:TROV) with
                                a buy rating.

PR Newswire

NEW YORK, May 6, 2013

NEW YORK, May 6, 2013 /PRNewswire/ --Today Highline Research Advisors
initiated coverage through Empire Asset Management Company, a FINRA member
(143007) of Trovagene (NASDAQ:TROV) with a BUY rating and 12 month price
target of $17.00

SOURCE Empire Asset Management Company

Contact: David Moskowitz, 212-417-8029
 
Press spacebar to pause and continue. Press esc to stop.